enVVeno Medical Corporation (NVNO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol NVNO
- Company enVVeno Medical Corporation
- Price $0.37
- Changes Percentage -11.43
- Change -0.048
- Day Low $0.36
- Day High $0.4
- Year High $5.62
- Year Low $0.36
- Market Cap $7,518,396
- Price Avg 50 EMA (D) $0.8
- Price Avg 200 EMA (D) $2.75
- Exchange NASDAQ
- Volume 2,062,143
- Average Volume 1,085,487
- Open $0.37
- Previous Close $0.42
- EPS -1.08
- PE -0.34
- Earnings Announcement 2026-02-26 05:00:00
- Shares Outstanding $20,216,176
Company brief: ENVVENO MEDICAL CORPORATION (NVNO )
- Healthcare
- Medical - Devices
- Mr. Robert A. Berman
- https://www.envveno.com
- US
- N/A
- 05-31-2018
- US29415J1060
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.